Elevated Enhancer-Oncogene Contacts and Higher Oncogene Expression Levels By Recurrent CTCFinactivating Mutations in T Cell Acute Lymphoblastic Leukemia

MLA

Smits, Willem K., et al. “Elevated Enhancer-Oncogene Contacts and Higher Oncogene Expression Levels By Recurrent CTCFinactivating Mutations in T Cell Acute Lymphoblastic Leukemia.” Blood, vol. 138, no. 1, Number 1 Supplement 1, Nov. 2021, p. 501. EBSCOhost, https://doi.org/10.1182/blood-2021-152221.

APA

Smits, W. K., Vermeulen, C., Hagelaar, R., Kimura, S., Vroegindeweij, E., Buijs-Gladdines, J. G. C. A. M., Van De Geer, E., Verstegen, M. J. A. M., Splinter, E., van Reijmersdal, S. V., Buijs, A., Galjart, N., Van Eyndhoven, W., Van Min, M. J., Kuiper, R. P., Kemmeren, P., Mullighan, C. G., De Laat, W., & Meijerink, J. P. P. (2021). Elevated Enhancer-Oncogene Contacts and Higher Oncogene Expression Levels By Recurrent CTCFinactivating Mutations in T Cell Acute Lymphoblastic Leukemia. Blood, 138(1, Number 1 Supplement 1), 501. https://doi.org/10.1182/blood-2021-152221

Chicago

Smits, Willem K., Carlo Vermeulen, Rico Hagelaar, Shunsuke Kimura, Eric Vroegindeweij, Jessica G.C.A.M. Buijs-Gladdines, Ellen Van De Geer, et al. 2021. “Elevated Enhancer-Oncogene Contacts and Higher Oncogene Expression Levels By Recurrent CTCFinactivating Mutations in T Cell Acute Lymphoblastic Leukemia.” Blood 138 (1, Number 1 Supplement 1): 501. doi:10.1182/blood-2021-152221.